Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Why Meta Platforms Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket

Gainers

  • View, Inc. (NASDAQ:VIEW) rose 23.2% to $1.30 in pre-market trading after declining 9% on Wednesday.
  • Kaixin Auto Holdings (NASDAQ:KXIN) shares rose 16.5% to $0.6532 in pre-market trading after reporting unaudited first half 2022 financial results.
  • Verb Technology Company, Inc. (NASDAQ:VERB) rose 16.1% to $0.3381 in pre-market trading. Verb Technology shares dropped around 13% on Wednesday after the company announced a $4 million registered direct offering.
  • ESSA Pharma Inc. (NASDAQ:EPIX) rose 16% to $5.57 in pre-market trading after jumping 180% on Wednesday. ESSA Pharma recently highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.
  • ServiceNow, Inc. (NYSE:NOW) rose 12.4% to $412.00 in pre-market trading after the company reported better-than-expected Q3 EPS results.
  • Kirkland's, Inc. (NASDAQ:KIRK) shares rose 10.8% to $4.00 in pre-market trading after declining 3% on Wednesday.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) rose 10.5% to $0.1345 in pre-market trading after dropping around 10% on Wednesday.
  • Teladoc Health, Inc. (NASDAQ:TDOC) shares rose 9.3% to $29.23 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results.
  • Healthcare Triangle, Inc. (NASDAQ:HCTI) rose 7.7% to $0.3550 in pre-market trading after dipping around 20% on Wednesday.
  • OneMain Holdings, Inc. (NYSE:OMF) rose 7.5% to $35.00 in pre-market trading following upbeat quarterly earnings.
  • Aegon N.V.. (NYSE:AEG) rose 7.2% to $4.63 in pre-market trading. Aegon announced plans to combine its Dutch operations with a.s.r.
  • RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 7.1% to $0.7140 in pre-market trading. Redhill Biopharma recently announced its oral broad-acting antiviral, Opaganib, was granted a new COVID-19 treatment patent.
  • Anheuser-Busch InBev SA/NV (NYSE:BUD) shares rose 6.8% to $50.45 in pre-market trading following Q3 results.


Don’t forget to check out our premarket coverage here .


Losers

  • Kalera Public Limited Company (NASDAQ:KAL) shares fell 59.1% to $0.0860 in pre-market trading. Kalera priced its 68 million unit public offering at $0.13 per unit.
  • Wolfspeed, Inc. (NASDAQ:WOLF) fell 24.2% to $80.70 in pre-market trading after the company issued Q2 sales guidance below estimates.
  • Meta Platforms, Inc. (NASDAQ:META) shares fell 20.1% to $103.68 in pre-market trading after the company reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion.
  • Align Technology, Inc. (NASDAQ:ALGN) fell 18.8% to $179.99 in pre-market trading after the company reported worse-than-expected Q3 results.
  • FedNat Holding Company (NASDAQ:FNHC) fell 17.3% to $0.3475 in pre-market trading after the company announced voluntary Nasdaq delisting.
  • Freight Technologies, Inc. (NASDAQ:FRGT) fell 15.4% to $0.50 in pre-market trading after jumping 37% on Wednesday.
  • RLX Technology Inc. (NYSE:RLX) shares fell 12.8% to $1.42 in pre-market trading after jumping 43% on Wednesday.
  • Credit Suisse Group AG (NYSE:CS) shares fell 9.8% to $4.32 in pre-market trading. Credit Suisse Group posted a Q3 loss of $1.58 per share.
  • Bionano Genomics, Inc.. (NASDAQ:BNGO) fell 9.4% to $2.30 in pre-market trading after gaining over 8% on Wednesday.
  • STMicroelectronics N.V. (NYSE:STM) fell 6.8% to $32.23 in pre-market trading following Q3 results.
  • Tricida, Inc. (NASDAQ:TCDA) fell 6.7% to $0.4359 in pre-market trading after declining 15% on Wednesday.
  • LendingClub Corporation (NYSE:LC) shares fell 5.8% to $10.98 in pre-market trading after the company issued Q4 guidance below estimates.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.